You are here

Handheld PDA Software Expanded To Include More Drug Data

GREENWOOD VILLAGE, Colo., April 22 /PRNewswire-FirstCall/ -- MICROMEDEX, a part of The Thomson Corporation (TSX: TOC; NYSE: TOC), announced today the expansion of a popular drug information product available to clinicians through mobileMICROMEDEX™. Information on more than 3,200 drugs was expanded to include additional data, making this information the most clinically relevant available via a handheld device.

"We are currently undertaking an exciting project that will help us quickly respond to clinicians' information needs by creating the content they want," said Michael Soares, vice president of editorial for MICROMEDEX. "Here is a great example-our customers asked for these enhancements, and we were able to react quickly to meet their request."

The new information now available in mobileMICROMEDEX includes: -- Precaution information allowing clinicians to reference populations that may use a particular drug with caution. -- Drug monitoring information enabling clinicians to quickly reference necessary lab tests and potential signs and symptoms to watch for when a patient is prescribed a particular drug. -- Recommended doses for patients requiring dose adjustments permitting clinicians to reference dosing for special populations such as pediatrics, geriatrics, or those with hepatic insufficiency, etc. -- Indications now divided by "FDA labeled" and "non-FDA labeled" reassuring clinicians about their decision to use a drug for a particular indication. -- Adverse effects separated into "common" and "serious" helping clinicians make more informed decisions as in how to handle an adverse reaction.

This enhancement is also available to MICROMEDEX® Healthcare Series customers through personal computer applications. For detailed information about mobileMICROMEDEX™, call (800) 525-9083 (+1-303-486-6444 outside the U.S.) or visit .

About Thomson MICROMEDEX

MICROMEDEX has been providing knowledge-based information for healthcare, safety, and the environment since 1974. Today, MICROMEDEX is relied upon in over 9,000 facilities in more than 92 countries. The Thomson Corporation, with 2002 revenues of $7.8 billion, is a global leader in providing integrated information solutions to business and professional customers. Thomson provides value-added information, software tools, and applications to more than 20 million users in the fields of law, tax, accounting, financial services, higher education, reference information, corporate training and assessment, scientific research, and healthcare. The Corporation's common shares are listed on the Toronto and New York stock exchanges (TSX: TOC; NYSE: TOC).

Recent Headlines

Despite older, sicker patients, mortality rate fell by a third in 10 years
Study finds fewer than half of trials followed the law
WHO to meet tomorrow to decide on international public heath emergency declaration
Study of posted prices finds wild variations and missing data
Potential contamination could lead to supply chain disruptions
Acasti reports disappointing results for a second Omega-3-based drug
Declining lung cancer mortality helped fuel the progress
Kinase inhibitor targets tumors with a PDGFRA exon 18 mutation
Delayed surgery reduces benefits; premature surgery raises risks